Literature DB >> 23722562

TGF-β1 induces the dissolution of tight junctions in human renal proximal tubular cells: role of the RhoA/ROCK signaling pathway.

Ke Zhang1, Hao Zhang, Hui Xiang, Jishi Liu, Yan Liu, Xianming Zhang, Jianwen Wang, Youzhou Tang.   

Abstract

The RhoA/ROCK signaling pathway plays a significant role in transforming growth factor (TGF)-β1-mediated epithelial-mesenchymal transition (EMT). It remains unclear, however, whether the RhoA/ROCK signaling pathway mediates TGF-β1-induced EMT by promoting the dissolution of tight junctions (TJs) in renal proximal tubular epithelial cells. In this study, we aimed to investigate the association between TGF-β1-mediated Rho/ROCK signaling and TJs in a cell line derived from human renal proximal tubular cells (HK-2 cells). HK-2 cells were treated with 5 ng/ml TGF-β1 for 0, 12, 24 and 48 h. Zona occludens protein 1 (also known as tight junction protein 1; ZO-1) and occludin mRNA and protein levels were determined by real-time PCR and western blot analysis, respectively. The HK-2 cells were then divided into three groups: a control group (serum-free culture medium for 24 h); a TGF-β1 group (treated with 5 ng/ml TGF-β1 for 24 h); and a TGF-β1 + Y-27632 (a specific ROCK inhibitor) group (pre-treated with 10 µM Y-27632 for 2 h and subsequently treated with 5 ng/ml TGF-β1 for 24 h). The levels of ZO-1 and occludin were detected by real-time PCR, western blot analysis and immunofluorescence. As shown by our results, the mRNA and protein levels of ZO-1 and occludin were decreased in the HK-2 cells following treatment with TGF-β1 in a time-dependent manner; in addition, ZO-1 and occludin levels in the TGF-β1 + Y-27632 group were significantly increased compared with those of the TGF-β1 group (P<0.05), with no significant changes compared with the control group. Our results indicate that the Rho/ROCK signaling pathway mediated by TGF-β1 plays a role in the dissolution of TJs during EMT.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23722562     DOI: 10.3892/ijmm.2013.1396

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  21 in total

1.  Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.

Authors:  Min-Kyung Kang; Sin-Hye Park; Yean-Jung Choi; Daekeun Shin; Young-Hee Kang
Journal:  J Mol Med (Berl)       Date:  2015-06-11       Impact factor: 4.599

2.  Improving viability and transfection efficiency with human umbilical cord wharton's jelly cells through use of a ROCK inhibitor.

Authors:  Adam J Mellott; Megan E Godsey; Heather E Shinogle; David S Moore; M Laird Forrest; Michael S Detamore
Journal:  Cell Reprogram       Date:  2014-02-19       Impact factor: 1.987

3.  RhoA/ROCK signaling regulates TGFβ-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A.

Authors:  Anna Korol; Aftab Taiyab; Judith A West-Mays
Journal:  Mol Med       Date:  2016-09-29       Impact factor: 6.354

4.  RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition.

Authors:  Yong-Eun Kim; Minho Won; Sung-Gwon Lee; Chungoo Park; Chang-Hwa Song; Kee K Kim
Journal:  Oncogene       Date:  2019-07-29       Impact factor: 9.867

Review 5.  RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.

Authors:  Qianyi Lu; Li Lu; Wei Chen; Haibing Chen; Xun Xu; Zhi Zheng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

6.  A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System.

Authors:  Arunima Sengupta; Nuria Roldan; Mirjam Kiener; Laurène Froment; Giulia Raggi; Theo Imler; Lea de Maddalena; Aude Rapet; Tobias May; Patrick Carius; Nicole Schneider-Daum; Claus-Michael Lehr; Marianna Kruithof-de Julio; Thomas Geiser; Thomas Michael Marti; Janick D Stucki; Nina Hobi; Olivier T Guenat
Journal:  Front Toxicol       Date:  2022-06-17

7.  1,25-(OH)2D3 and its analogue BXL-628 inhibit high glucose-induced activation of RhoA/ROCK pathway in HK-2 cells.

Authors:  Wei Zhang; Bin Yi; Ke Zhang; Aimei Li; Shikun Yang; Jing Huang; Jishi Liu; Hao Zhang
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

Review 8.  RhoGTPases, actomyosin signaling and regulation of the epithelial Apical Junctional Complex.

Authors:  Miguel Quiros; Asma Nusrat
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

9.  Transforming growth factor beta 1 impairs benign prostatic luminal epithelial cell monolayer barrier function.

Authors:  Feng Li; Laura E Pascal; Ke Wang; Yibin Zhou; Goundappa K Balasubramani; Katherine J O'Malley; Rajiv Dhir; Kai He; Donna Stolz; Donald B DeFranco; Naoki Yoshimura; Joel B Nelson; Tie Chong; Peng Guo; Dalin He; Zhou Wang
Journal:  Am J Clin Exp Urol       Date:  2020-02-25

10.  Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: implications for age-related macular degeneration.

Authors:  Monte J Radeke; Carolyn M Radeke; Ying-Hsuan Shih; Jane Hu; Dean Bok; Lincoln V Johnson; Pete J Coffey
Journal:  Genome Med       Date:  2015-06-19       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.